ACE Pharmaceuticals has sold a majority stake to private investors and Quadrum Capital

The shareholders of ACE Pharmaceuticals have sold a majority stake in the company to private investors and Quadrum Capital, a Dutch private equity firm.

ACE Pharmaceuticals is a specialized company operating in the niche of medical need products which provide mainly small patient groups or specific indications. Through new, innovative products or by the revitalization of orphaned drugs, the company is able to ensure that these medical need products are or remain available. The company develops and distributes locally and abroad both licensed and non-licensed products. ACE Pharmaceuticals was founded more than 25 years ago as a producer of veterinary medicines. In the early 2000s, the company shifted its focus to human medical need products. Since then, it has experienced strong sales growth and has built an exciting product range and promising product pipeline.

Oaklins's team in the Netherlands acted as M&A advisor to the shareholders of ACE Pharmaceuticals in this transaction.